Revvity Inc

RVTYNYSE
$147.35
7.165.11%
Last update: Sep 16, 2:14 PM
M&A: Human Cell Design (HCD) announced it will be acquired by Revvity (RVTY) on Wednesday, September 9, 2026

Revvity Market Sentiment

Market sentiment signals for Revvity (RVTY): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus Buy
Short Interest 8.5% short float
Options Flow 1.17 P/C ratio
Insider Activity N/A

Analyst Consensus

Buy

25 analysts

Options Flow (P/C)

1.17

More puts — Bearish

157 calls · 184 puts

Avg Consensus PT

$117

-20.6%

Highest Price Target

$165

+12.0%

Keybanc

Lowest Price Target

$90

-38.9%

JP Morgan

Short Interest

8.5%

Declining — Bullish

Insider Activity (30d)

Short Interest — % of Float

Recent Analyst Actions

DateFirmAnalyst & AccuracyUpside / DownsidePT ChangeActionRating
Sep 9, 2026UBS
Doug Schenkel
-5.0%$120 → $140AssumesBuyNeutral
Sep 4, 2026Keybanc
Paul Knight
+12.0%$125 → $165MaintainedOverweight